VOR
Vor Biopharma Inc
NASDAQ: VOR · HEALTHCARE · BIOTECHNOLOGY
$14.33
+2.14% today
Updated 2026-04-30
Market cap
$702.43M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-70.50
Dividend yield
—
52W range
$3 – $66
Volume
1.1M
Vor Biopharma Inc (VOR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.66M | $-9.86M | $-36.29M | $-69.14M | $-85.14M | $-100.29M | $-99.66M | $-142.71M |
| Capital expenditures | $748000.00 | $748000.00 | $4.16M | $3.89M | $8.46M | $1.07M | $229000.00 | $941000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $116000.00 | $172000.00 | $1.34M | $4.32M | $10.70M | $13.36M | $9.85M | $18.91M |
| Free cash flow | $-3.41M | $-10.60M | $-40.45M | $-73.04M | $-93.61M | $-101.36M | $-99.89M | $-143.65M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $72.12M | $-62.09M | — | — | — |